Docaravimab
Based on 1 Customer Validation
Docaravimab is an antibody, targeting ERA (Evelyn-Rockitniki-Abelseth) glycoprotein ectodomain epitope G-III. Docaravimab can be used in research of Rabies.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity : 99.27%
- CAS No.: 2247196-23-0
- 분자량:146.48 kDa
-
보관:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
Isotype
Mouse IgG2b kappa
Recommend Isotype Controls
Species Reactivity
Rabies lyssavirus
IC50 & Target
ERA
Conjugated
Unconjugated
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
IgG2b-kappa
신청
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized human Rabies virus Glycoprotein G His Tag can bind Docaravimab. The EC50 for this effect is 12.13 ng/mL.
Chemical Information
-
CAS No. 2247196-23-0
-
Appearance Liquid
-
분자량 146.48 kDa
-
Color Colorless to light yellow
-
SMILES
[Docaravimab]
-
Synonyms
62-71-3
-
선적
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
-
Data Sheet (257 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)